Clinical Trial Update: Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I) [Phase 2]

View source ↗

Summary

RAPID-I is a Phase 2 randomized, double-blind, placebo-controlled multicenter trial evaluating infliximab for acute pancreatitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: University of Liverpool | Conditions: Acute Pancreatitis | Phase 2 | Status: RECRUITING